PATENT CLAIM ANALYSIS

Application Number: 16051879
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["544", "264000"]

Abstract:
The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: where R 1 , R 2 , R 3 , R 3′ , R 4 , R 5 , X 1 , X 2 , X 3 , X 4 , and n are described herein.

Claim (Index 55):
The composition of  claim 53 , further comprising a compound B-2:

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.8
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15355887', '15988790', '15937271', '16029166', '14546896']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7257315789694413
- 35 USC 102 Novelty (BERT): 0.5374128524989575
- Combined Prediction Score: 0.706899706322393
- Mean Citation Score: 293.533814
- Max Citation Score: 371.9852
- Similarity Product: 285.85050515720843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test